146 related articles for article (PubMed ID: 17515896)
1. Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists.
Buonpane RA; Churchill HR; Moza B; Sundberg EJ; Peterson ML; Schlievert PM; Kranz DM
Nat Med; 2007 Jun; 13(6):725-9. PubMed ID: 17515896
[TBL] [Abstract][Full Text] [Related]
2. Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1.
Buonpane RA; Moza B; Sundberg EJ; Kranz DM
J Mol Biol; 2005 Oct; 353(2):308-21. PubMed ID: 16171815
[TBL] [Abstract][Full Text] [Related]
3. Superantigen natural affinity maturation revealed by the crystal structure of staphylococcal enterotoxin G and its binding to T-cell receptor Vbeta8.2.
Fernández MM; Bhattacharya S; De Marzi MC; Brown PH; Kerzic M; Schuck P; Mariuzza RA; Malchiodi EL
Proteins; 2007 Jul; 68(1):389-402. PubMed ID: 17427250
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of a T-cell receptor beta-chain complexed with a superantigen.
Fields BA; Malchiodi EL; Li H; Ysern X; Stauffacher CV; Schlievert PM; Karjalainen K; Mariuzza RA
Nature; 1996 Nov; 384(6605):188-92. PubMed ID: 8906797
[TBL] [Abstract][Full Text] [Related]
5. High affinity T cell receptors from yeast display libraries block T cell activation by superantigens.
Kieke MC; Sundberg E; Shusta EV; Mariuzza RA; Wittrup KD; Kranz DM
J Mol Biol; 2001 Apr; 307(5):1305-15. PubMed ID: 11292343
[TBL] [Abstract][Full Text] [Related]
6. Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock.
Arad G; Hillman D; Levy R; Kaempfer R
J Leukoc Biol; 2001 Jun; 69(6):921-7. PubMed ID: 11404377
[TBL] [Abstract][Full Text] [Related]
7. Engineering a soluble high-affinity receptor domain that neutralizes staphylococcal enterotoxin C in rabbit models of disease.
Mattis DM; Spaulding AR; Chuang-Smith ON; Sundberg EJ; Schlievert PM; Kranz DM
Protein Eng Des Sel; 2013 Feb; 26(2):133-42. PubMed ID: 23161916
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the Staphylococcal enterotoxin A: Vβ receptor interaction using human receptor fragments engineered for high affinity.
Sharma P; Postel S; Sundberg EJ; Kranz DM
Protein Eng Des Sel; 2013 Dec; 26(12):781-9. PubMed ID: 24167300
[TBL] [Abstract][Full Text] [Related]
9. A single, engineered protein therapeutic agent neutralizes exotoxins from both Staphylococcus aureus and Streptococcus pyogenes.
Wang N; Mattis DM; Sundberg EJ; Schlievert PM; Kranz DM
Clin Vaccine Immunol; 2010 Nov; 17(11):1781-9. PubMed ID: 20861327
[TBL] [Abstract][Full Text] [Related]
10. A broad-spectrum inhibitory peptide against staphylococcal enterotoxin superantigen SEA, SEB and SEC.
Wang S; Li Y; Xiong H; Cao J
Immunol Lett; 2008 Dec; 121(2):167-72. PubMed ID: 19028523
[TBL] [Abstract][Full Text] [Related]
11. Modeling of receptor mimics that inhibit superantigen pathogenesis.
Möllhoff M; Zanden HB; Shiflett PR; Gupta G
J Mol Recognit; 2005; 18(1):73-83. PubMed ID: 15459942
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcus aureus isolates encode variant staphylococcal enterotoxin B proteins that are diverse in superantigenicity and lethality.
Kohler PL; Greenwood SD; Nookala S; Kotb M; Kranz DM; Schlievert PM
PLoS One; 2012; 7(7):e41157. PubMed ID: 22815951
[TBL] [Abstract][Full Text] [Related]
13. Contribution of the flexible loop region to the function of staphylococcal enterotoxin B.
Yanaka S; Kudou M; Tanaka Y; Sasaki T; Takemoto S; Sakata A; Hattori Y; Koshi T; Futaki S; Tsumoto K; Nakashima T
Protein Eng Des Sel; 2010 May; 23(5):415-21. PubMed ID: 20181657
[TBL] [Abstract][Full Text] [Related]
14. [Study on the TCR Vbeta binding sites in the superantigen staphylococcal enterotoxin D].
Li YF; Zhong L; Zhu XH; Zhu XH; Yang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):757-9. PubMed ID: 15555455
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the streptococcal superantigen SpeI and functional role of a novel loop domain in T cell activation by group V superantigens.
Brouillard JN; Günther S; Varma AK; Gryski I; Herfst CA; Rahman AK; Leung DY; Schlievert PM; Madrenas J; Sundberg EJ; McCormick JK
J Mol Biol; 2007 Apr; 367(4):925-34. PubMed ID: 17303163
[TBL] [Abstract][Full Text] [Related]
16. Defense against biologic warfare with superantigen toxins.
Kaempfer R; Arad G; Levy R; Hillman D
Isr Med Assoc J; 2002 Jul; 4(7):520-3. PubMed ID: 12120463
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase 2 pathway and its therapeutic inhibition in superantigen-induced toxic shock.
Rajagopalan G; Asmann YW; Lytle AK; Tilahun AY; Theuer JE; Smart MK; Patel R; David CS
Shock; 2008 Dec; 30(6):721-8. PubMed ID: 18496243
[TBL] [Abstract][Full Text] [Related]
18. Acute systemic immune activation following vaginal exposure to staphylococcal enterotoxin B--implications for menstrual shock.
Rajagopalan G; Smart MK; Murali N; Patel R; David CS
J Reprod Immunol; 2007 Feb; 73(1):51-9. PubMed ID: 17070600
[TBL] [Abstract][Full Text] [Related]
19. Biological properties of staphylococcal enterotoxin-like toxin type R.
Omoe K; Imanishi K; Hu DL; Kato H; Takahashi-Omoe H; Nakane A; Uchiyama T; Shinagawa K
Infect Immun; 2004 Jun; 72(6):3664-7. PubMed ID: 15155681
[TBL] [Abstract][Full Text] [Related]
20. Structure-based design of a bispecific receptor mimic that inhibits T cell responses to a superantigen.
Lehnert NM; Allen DL; Allen BL; Catasti P; Shiflett PR; Chen M; Lehnert BE; Gupta G
Biochemistry; 2001 Apr; 40(14):4222-8. PubMed ID: 11284677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
